Peritoneal dialysis

Intraperitoneal nebulization of ropivacaine reduced postoperative pain, fentanyl consumption, referred shoulder pain, and PONV while enabling earlier mobility without any difference in the length of hospital stay.

Peritoneal dialysis provides a variety of benefits over hemodialysis, making it the ‘ideal’ mode of renal replacement therapy for patients prior to kidney transplantation, according to researchers from the University of Hong Kong.

Covid-19 has forced the postponement of many surgical procedures, but Dr Sunita Bavanandan, the president of the Malaysian Society of Nephrology, told FMT government hospitals had continued to perform the simple and low-risk peritoneal dialysis (PD) access procedure.

Our Peritoneal Dialysis Belt discreetly and securely holds the entire dialysis tube in place, giving you the confidence to live a normal life.

Patients on peritoneal dialysis who received daily probiotic supplementation saw improvements in measures related to malnutrition and health-related quality of life, according to results of a randomized controlled trial conducted in China.

PD is a very effective dialysis modality and maintains better 3-year survival, while being approximately $14,000 per patient per year cheaper than ICHD. Consequently, under these value-based pay for performance models, PD in the US increased significantly since 2011.

Greater use of automated PD was significantly associated with lower peritonitis risk, with the risk decreasing by 5% with each 10 percentage point increase in the proportion of patients using this modality, after adjusting for patient factors.

Peritoneal dialysis (PD) catheters are one of the most successful long-term transcutaneous access devices ever used in medical practice. The catheter, if successfully placed can provide successful dialysis for years. For the above to be accomplished, various components of the catheter must be precisely placed in different tissues and spaces, such as the lower part of the peritoneal cavity, the rectus muscle, and the subcutaneous space. POCUS is an invaluable tool not only to guide the percutaneous placement of the catheter but also to confirm the appropriate locations and diagnose complications such as infection at the bedside. In this post, we will discuss some scenarios where POCUS can provide useful diagnostic information in PD patients.

Insertion of a peritoneal dialysis (PD) catheter is frequently done by interventional nephrologists, but these procedures are typically only performed for adults. Almost all invasive procedures in children are performed by pediatric surgeons. If a pediatric surgeon is unavailable, the initiation of PD in acute situations may be delayed, thus increasing the risk of complications and chronic kidney disease. For these patients, the main obstacle to initiating renal replacement therapy is access, even when involving central vein catheter (CVC) or peritoneal access.

More than half of all women experience at least one episode of urinary tract infection (UTI) in their lifetime, with men also facing increasing risks of infection as they age. Current detection of UTIs rely on patients reporting symptoms followed by a lab culture of the urine for known bacterial culprits, which typically takes a few days. However, doctors tend to prescribe antibiotics to suppress any suspect cases of UTI before they get the test results, contributing to the increasing problem of antibiotic resistance. Dipstick tests that reduce the time taken for diagnoses come with a high chance for false positives.

Overall, in two closely matched demographic groups of older dialysis patients, QOL was similar, if not better, in those on PD. This study strongly supports offering PD to all suitable older people.

Beep-Away Spring helps reduce the potential for tubing kinks during nighttime cycler PD * For Health and Safety only unopened, unused product may be returned for refund within 30 days. **NOTE: NOT SUITABLE FOR FRESENIUS STAY SAFE CONNECTORS

We describe for the first time the detection of SARS-CoV2 in the peritoneal waste of a patient with COVID19 and end-stage-kidney-disease on peritoneal dialysis. A 53 year old Caucasian female affected by fibrillary glomerulonephritis and on peritoneal dialysis since November 2019 was admitted to our Hospital on March 9th with fever, cough, headache, myalgia and mild hypoxemia. Chest Computed Tomography (CT) showed bilateral multiple ground-glass opacities but the initial nasopharyngeal swab for SARS-CoV2 was negative.

The Indian Council for Medical Research (ICMR) has clarified that Chronic Kidney Disease (CKD) patients on dialysis are vulnerable to COVID-19 because of their existing co-morbidities and repeated unavoidable exposure to the hospital environment and immunosuppressed state. This is where home-based dialysis therapy like Peritoneal Dialysis (PD) is coming to people’s rescue.

The clinical outcomes of gram-positive and culture-negative peritonitis episodes are not associated with either the frequency or levels of serum vancomycin measurements in the first week of treatment when vancomycin is dosed according to International Society for Peritoneal Dialysis (ISPD) Guidelines.